Rare diseases
Investigational molecules
Locations
1 B Rue De L Internationale, 91000, France
Atamyo Therapeutics focuses on inherited muscle disorders within the limb-girdle muscular dystrophy spectrum, with clinical work centered on FKRP-related limb-girdle muscular dystrophy and limb-girdle muscular dystrophy type R5.
The sponsor’s clinical portfolio is directed toward neuromuscular conditions affecting mobility and skeletal muscle function in ambulant patients.
Atamyo Therapeutics runs clinical trials in conditions such as Muscular dystrophy, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
France
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
